Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis

BACKGROUND: Platinum-based chemotherapy improves survival among patients with non-small cell lung cancer (NSCLC), but the efficiency is limited due to resistance. In this study, we aimed to identify the expression of Aurora-A and its correlation with cisplatin resistance and prognosis in NSCLC. METH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Xu, Jie, Yue, Cai-feng, Zhou, Wei-hua, Qian, Yuan-min, Zhang, Yan, Wang, Shao-wu, Liu, An-wen, Liu, Quentin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4237886/
https://ncbi.nlm.nih.gov/pubmed/25082261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars